相关实验视频
Updated: Jan 18, 2026

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
36.5K
在癌症进展和药物耐药性方面的TGF-β驱动的EMT
Wen Luo1, Qingfeng Shi2, Mingming Han3
1Department of Oncology, Suining Central Hospital, Suining, Sichuan, China.
Cytokine & growth factor reviews
|May 28, 2025
概括
转化生长因子-β (TGF-β) 通过增强表皮-介质细胞转换 (EMT) 加快癌症,促进转移和耐药性. 针对TGF-β诱导的EMT为癌症治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 转化生长因子-β (TGF-β) 是一种关键的调节剂,与癌症进展有关.
- 众所周知,TGF-β信号增强了表皮细胞-介质细胞过渡 (EMT),这是对瘤转移和治疗耐药性至关重要的过程.
研究的目的:
- 审查TGF-β驱动EMT跨越各种瘤的复杂机制.
- 突出TGF-β在增加细胞可塑性,促进转移和促进治疗耐药性的作用.
- 检查针对TGF-β诱导的EMT的潜在治疗策略.
主要方法:
- 对TGF-β信号通路 (规范性Smad依赖和非规范性) 的现有文献的综述.
- 分析TGF-β与控制EMT的分子通路 (例如PI3K/AKT,MAPK,表观遗传调节器) 的相互作用.
- 对新型治疗化合物和组合疗法的临床前数据的评估.
主要成果:
- TGF-β的激活导致细胞形态,运动性和干性发生显著变化.
- TGF-β在调节癌症干细胞和调节化学疗法和向疗法的耐药性方面发挥着至关重要的作用.
- TGF-β与关键信号通路之间的相互作用强调了其在癌症中的多方面的作用.
结论:
- 理解TGF-β驱动的EMT机制对于开发有效的癌症疗法至关重要.
- 针对TGF-β受体激活或下游途径在临床前研究中显示出有希望的结果.
- 需要进一步的研究来解决知识差距,并探索TGF-β向癌症治疗的未来方向.
相关概念视频
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K

